Skip to main content
Biochemical Journal logoLink to Biochemical Journal
. 1981 Jun 15;196(3):899–902. doi: 10.1042/bj1960899

Effect of serum lipoproteins on the adenylate cyclase activity of rat liver plasma membranes.

G Ghiselli, C R Sirtori, S Nicosia
PMCID: PMC1163113  PMID: 7317023

Abstract

Four rat lipoprotein classes [lymph chylomicrons, VLD (very-low-density), LD (low-density) and HD (high-density) lipoproteins] were tested for their ability to affect basal adenylate cyclase (EC 4.6.1.1) activity of rat liver plasma membranes. All the lipoproteins, with the exception of lymph chylomicrons, effectively increase the enzyme activity. VLD lipoproteins are the most active class (67% maximal increase), followed by HD lipoproteins (33%) and LD lipoproteins (23%). The effect of VLD lipoproteins is additive to that elicited by GTP or GTP plus glucagon (at least within a certain concentration range). VLD lipoproteins affect only the Vmax. of the enzyme, not the Km.

Full text

PDF
899

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BASFORD J. M., GLOVER J., GREEN C. EXCHANGE OF CHOLESTEROL BETWEEN HUMAN BETA-LIPOPROTEINS AND ERYTHROCYTES. Biochim Biophys Acta. 1964 Dec 2;84:764–766. doi: 10.1016/0926-6542(64)90039-3. [DOI] [PubMed] [Google Scholar]
  2. Brown M. S., Goldstein J. L. Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man. Science. 1974 Jul 5;185(4145):61–63. doi: 10.1126/science.185.4145.61. [DOI] [PubMed] [Google Scholar]
  3. George R., Ramasarma T. Nature of the stimulation of biogenesis of cholesterol in the liver by noradrenaline. Biochem J. 1977 Mar 15;162(3):493–499. doi: 10.1042/bj1620493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Goldstein J. L., Brown M. S. Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. Proc Natl Acad Sci U S A. 1973 Oct;70(10):2804–2808. doi: 10.1073/pnas.70.10.2804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goldstein J. L., Brown M. S. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897–930. doi: 10.1146/annurev.bi.46.070177.004341. [DOI] [PubMed] [Google Scholar]
  6. Heimberg M., Weinstein I., Kohout M. The effects of glucagon, dibutyryl cyclic adenosine 3',5'-monophosphate, and concentration of free fatty acid on hepatic lipid metabolism. J Biol Chem. 1969 Oct 10;244(19):5131–5139. [PubMed] [Google Scholar]
  7. Houslay M. D., Hesketh T. R., Smith G. A., Warren G. B., Metcalfe J. C. The lipid environment of the glucagon receptor regulates adenylate cyclase activity. Biochim Biophys Acta. 1976 Jun 17;436(2):495–504. doi: 10.1016/0005-2736(76)90211-x. [DOI] [PubMed] [Google Scholar]
  8. Neville D. M., Jr Isolation of an organ specific protein antigen from cell-surface membrane of rat liver. Biochim Biophys Acta. 1968 Apr 9;154(3):540–552. doi: 10.1016/0005-2795(68)90014-7. [DOI] [PubMed] [Google Scholar]
  9. Pairault J., Levilliers J., Chapman M. J. Human serum lipoproteins activate adipocyte plasma membrane adenylate cyclase. Nature. 1977 Oct 13;269(5629):607–609. doi: 10.1038/269607a0. [DOI] [PubMed] [Google Scholar]
  10. Pohl S. L., Birnbaumer L., Rodbell M. The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. I. Properties. J Biol Chem. 1971 Mar 25;246(6):1849–1856. [PubMed] [Google Scholar]
  11. Rodriguez J., Catapano A., Ghiselli G. C., Sirtori C. R. Turnover and aortic uptake of very low density lipoproteins (VLDL) from hypercholesteremic rabbits as a model for testing antiatherosclerotic compounds. Adv Exp Med Biol. 1976;67(00):169–189. doi: 10.1007/978-1-4614-4618-7_10. [DOI] [PubMed] [Google Scholar]
  12. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974 Apr;58(2):541–548. doi: 10.1016/0003-2697(74)90222-x. [DOI] [PubMed] [Google Scholar]
  13. Schonfeld G., Patsch W., Pfleger B., Witztum J. L., Weidman S. W. Lipolysis produces changes in the immunoreactivity and cell reactivity of very low density lipoproteins. J Clin Invest. 1979 Nov;64(5):1288–1297. doi: 10.1172/JCI109584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Shore V., Shore B. Stimulation of human erythrocyte Mg++ -ATPASE by plasma lipoproteins1. Biochem Biophys Res Commun. 1975 Aug 18;65(4):1250–1256. doi: 10.1016/s0006-291x(75)80364-0. [DOI] [PubMed] [Google Scholar]
  15. Sinha A. K., Shattil S. J., Colman R. W. Cyclic AMP metabolism in cholesterol-rich platelets. J Biol Chem. 1977 May 25;252(10):3310–3314. [PubMed] [Google Scholar]
  16. Taylor R. G., Lewis J. C., Rudel L. L., Biddulph D. M. Low density lipoprotein modulation of CAMP in avian thrombocytes. Thromb Res. 1979;14(4-5):799–803. doi: 10.1016/0049-3848(79)90135-x. [DOI] [PubMed] [Google Scholar]
  17. Willingham M. C., Pastan I. The receptosome: an intermediate organelle of receptor mediated endocytosis in cultured fibroblasts. Cell. 1980 Aug;21(1):67–77. doi: 10.1016/0092-8674(80)90115-4. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES